Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

Binozyt Powder for Oral Suspension 200mg/5ml

Approval Number

SIN13742P

Drug Name

Binozyt Powder for Oral Suspension 200mg/5ml

Product Name

Binozyt Powder for Oral Suspension 200mg/5ml

Approval Date

December 1, 2009

Registrant

NOVARTIS (SINGAPORE) PTE LTD

Regulatory Information

Registrant

NOVARTIS (SINGAPORE) PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

POWDER, FOR SUSPENSION

Route of Administration

ORAL

Medical Information

ATC Code

J01FA10

ATC Item Name

azithromycin

Manufacturer Information

Pharmaceutical Manufacturer

NOVARTIS (SINGAPORE) PTE LTD

Manufacturers

Sandoz S.R.L.

Active Ingredients

Ingredient Name

Azithromycin Monohydrate 204.8mg eqv Azithromycin

Strength

200mg/5ml

Drug MonographAzithromycin

Documents

Package Inserts

1.4.3_PI_Binozyt POS 200mg5ml_Proposed MAY 2021.pdf

Approved: May 20, 2021

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy